Drugs News and Research

RSS

Majority of patients with ulcerative colitis eager to undergo fecal microbiota transplantation

The first study of the social and ethical issues associated with a provocative approach to treatment for ulcerative colitis has found that the majority of potential patients are eager for what is now called "fecal microbiota transplantation" to become available, although many have concerns about donor selection, screening, and methods of delivery.

3 Jun 2011

Insight into beneficial epilepsy treatments for children with autism

Physicians will have a better guide for more effectively managing treatment of children experiencing seizures related to autism with the results of a study by researchers at Arizona State University and the University of Texas-Houston.

3 Jun 2011

New report: Life science tools market to reach over $80B by 2016

The life science tools market will reach over $80 billion by 2016, according to a new report on companiesandmarkets.com. The life science tools market has shown steady growth over the last couple of years despite the economic downturn.

3 Jun 2011

New research aims to improve treatment of diabetes and cardiovascular diseases

New research at the University of Leicester to contribute to more effective drug design. A cutting-edge research project at the University of Leicester is aiming to improve the treatment of diabetes and cardiovascular diseases.

3 Jun 2011

Itraconazol may keep prostate cancer from worsening and delay need for chemotherapy in men

The oral antifungal drug itraconazole, most commonly used to treat nail fungus, may keep prostate cancer from worsening and delay the need for chemotherapy in men with advanced disease.

3 Jun 2011

Angiotensin receptor blockers do not increase risk of cancer: FDA

The U.S. Food and Drug Administration today announced that a group of medications used to control high blood pressure, called angiotensin receptor blockers (ARBs), do not increase the risk of developing cancer in patients using the medications.

3 Jun 2011

State roundup: Texas special session highlights health issues

States are slashing funding, and more cuts are expected. But in places like Reno, where police have teamed up with counselors to aid the mentally ill, the services don't seem expendable.

3 Jun 2011

Viewpoints raise questions: Can free market fix Medicare? Should military families pay more for health care?

If even a fraction of [the president's Medicare cuts] take place, a whopping 87 percent of doctors say they will stop seeing or will restrict the number of Medicare patients they see, further shrinking the pool of providers and further restricting access to care.

3 Jun 2011

Scientists identify protein sorting mechanism used by salivary gland

University of Louisville researchers are one step closer to helping millions of people whose salivary glands no longer work because of disease or damage from treatment of diseases.

3 Jun 2011

Scientists uncover new therapeutic target that could prevent stress-related cell death

Scientists from the Florida campus of The Scripps Research Institute have uncovered a potentially important new therapeutic target that could prevent stress-related cell death, a characteristic of neurodegenerative diseases such as Parkinson's, as well as heart attack and stroke.

3 Jun 2011

Green tea consumption increases number of 'regulatory T cells', prevents autoimmune disease

One of the beneficial compounds found in green tea has a powerful ability to increase the number of "regulatory T cells" that play a key role in immune function and suppression of autoimmune disease, according to new research in the Linus Pauling Institute at Oregon State University.

3 Jun 2011

VCU Massey completes Bortezomib-Alvocidib Phase I clinical trial against blood cancers

Clinical researchers at VCU Massey Cancer Center have successfully completed a Phase I clinical trial evaluating a combination of the drugs Bortezomib and Alvocidib in patients with relapsed or refractory blood cancers, paving the way for a Phase II clinical trial to test the safety and effectiveness of the new therapy.

3 Jun 2011

Celebrities urge decriminalization of drug possession

Dame Judi Dench, Sir Richard Branson, actress Julie Christies and Sting have added their support to an ex-drugs minister and three former chief constables in calling for the decriminalization of the possession of all drugs. These celebrities together with leading lawyers, academics, artists and politicians have signed an open letter to David Cameron to mark this week's 40th anniversary of the 1971 Misuse of Drugs Act. The letter, published in a full-page advertisement in Thursday's Guardian, calls for a “swift and transparent” review of the effectiveness of current drugs policies.

2 Jun 2011

First Edition: June 2, 2011

Today's health policy headlines cover a gamut of develoments, including reports about the latest Medicare dust up in the ongoing budget negotiations and about oral arguments in the latest round of appellate court action related to health law legal challenges.

2 Jun 2011

Protox reports net and comprehensive loss of $2.2 million for first quarter 2011

Protox Therapeutics Inc., a leader in the development of receptor targeted therapeutic fusion proteins, today announced financial results and achievements for the quarter ended March 31, 2011.

2 Jun 2011

Researchers explore relationship between emotions and poor prognosis in heart disease

Intense distress and fear of dying, which many people experience when suffering the symptoms of a heart attack, are not only fairly common emotional responses but are also linked to biological changes that occur during the event, according to new research published online today in the European Heart Journal.

2 Jun 2011

Repligen announces completion of RG1068 pre-New Drug Application meeting with U.S. FDA

Repligen Corporation today announced that the Company has concluded a pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration related to its lead product candidate, RG1068 for improvement of magnetic resonance imaging of the pancreas.

2 Jun 2011

Patients with advanced NSCLC can benefit from less toxic combination of erlotinib, bevacizumab

The standard treatment for patients with advanced non-small cell lung cancer is a combination of two old-fashioned cytotoxic chemotherapy drugs. The combination, however, comes with substantial toxicity.

2 Jun 2011

Sanofi, DNDi announce three-year research collaboration for neglected tropical diseases

The pharmaceutical company Sanofi and the Drugs for Neglected Diseases initiative (DNDi) on Monday announced a three-year research collaboration to develop drugs for nine neglected tropical diseases, RTTNews reports.

2 Jun 2011

Researchers discover overactive genes that drive triple-negative breast cancer cells

Scientists at Dana-Farber Cancer Institute have identified an overactive network of growth-spurring genes that drive stem-like breast cancer cells enriched in triple-negative breast tumors, a typically aggressive cancer that is highly resistant to current therapies.

2 Jun 2011

Drugs News and Research

Majority of patients with ulcerative colitis eager to undergo fecal microbiota transplantation

Insight into beneficial epilepsy treatments for children with autism

New report: Life science tools market to reach over $80B by 2016

New research aims to improve treatment of diabetes and cardiovascular diseases

Itraconazol may keep prostate cancer from worsening and delay need for chemotherapy in men

Angiotensin receptor blockers do not increase risk of cancer: FDA

State roundup: Texas special session highlights health issues

Viewpoints raise questions: Can free market fix Medicare? Should military families pay more for health care?

Scientists identify protein sorting mechanism used by salivary gland

Scientists uncover new therapeutic target that could prevent stress-related cell death

Green tea consumption increases number of 'regulatory T cells', prevents autoimmune disease

VCU Massey completes Bortezomib-Alvocidib Phase I clinical trial against blood cancers

Celebrities urge decriminalization of drug possession

First Edition: June 2, 2011

Protox reports net and comprehensive loss of $2.2 million for first quarter 2011

Researchers explore relationship between emotions and poor prognosis in heart disease

Repligen announces completion of RG1068 pre-New Drug Application meeting with U.S. FDA

Patients with advanced NSCLC can benefit from less toxic combination of erlotinib, bevacizumab

Sanofi, DNDi announce three-year research collaboration for neglected tropical diseases

Researchers discover overactive genes that drive triple-negative breast cancer cells

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News